This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Evive Biotechnology (Shanghai) Ltd, Memorial Sloan Kettering Cancer Center. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 625 
Years Active: 2023
Title: Caroline Lindemans: Innovator in Gastrointestinal Treatments
Introduction
Caroline Lindemans is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of medical science, particularly in the treatment of gastrointestinal conditions. Her innovative work focuses on the use of IL-22 in therapeutic applications.
Latest Patents
Caroline holds a patent for "Methods of use for IL-22 in the treatment of gastrointestinal graft vs. host disease." This invention provides methods and compositions for utilizing IL-22 to treat intestinal injuries and inflammatory conditions, such as graft vs. host disease. The patent emphasizes the potential of IL-22 to enhance Intestinal Stem Cell (ISC) recovery and improve immune reconstitution following allogeneic hematopoietic transplantation. The therapeutic applications include a dimeric form of IL-22 for treating various forms of graft vs. host disease in patients undergoing hematopoietic stem cell transplants.
Career Highlights
Throughout her career, Caroline has worked with esteemed institutions, including Memorial Sloan Kettering Cancer Center and Evive Biotechnology (Shanghai) Ltd. Her experience in these organizations has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Caroline has collaborated with notable professionals in her field, including Marcel Van Den Brink and Alan Hanash. These partnerships have further enriched her research and innovation efforts.
Conclusion
Caroline Lindemans is a trailblazer in the field of gastrointestinal treatments, with her patent on IL-22 showcasing her commitment to improving patient outcomes. Her work continues to inspire advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile